1 year ago
49
UK’s largest stock market-listed firm weighs up HK or Shanghai listing to shield it from growing geopolitical tensions
AstraZeneca is considering spinning off its business in China and listing it in Hong Kong or Shanghai to shield the multinational drugmaker from geopolitical tensions.
Britain’s largest stock market listed company has drawn up plans to spin out its Chinese division and list it separately in a move designed to protect its business from the fallout of mounting tensions between China and the US and its allies.
Continue reading...